Chem. J. Chinese Universities ›› 2021, Vol. 42 ›› Issue (11): 3310.doi: 10.7503/cjcu20210452

• Review • Previous Articles     Next Articles

Recent Advances in Fabricating the Multifunctional Aβ Small Organic Molecule Probes for Theranostic Application

CHEN Xiaoyu1,2, LIU Yisheng1, HE Mu, SHANGGUAN Ping1, HAN Lulu1, WANG Jiefei1,2(), SHI Bingyang1,2()   

  1. 1.Henan?Macquarie University Joint Centre for Biomedical Innovation,School of Life Sciences
    2.Henan Key Laboratory of Brain Targeted Bio?nanomedicine,School of Life Sciences & School of Pharmacy,Henan University,Kaifeng 475004,China
  • Received:2021-06-30 Online:2021-11-10 Published:2021-09-24
  • Contact: WANG Jiefei,SHI Bingyang E-mail:jfwang@henu.edu.cn;bs@henu.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(31800841);the Natural Science Foundation of Henan Province, China(202300410064);the Postdoctoral Research Grant in Henan Province, China(201903031)

Abstract:

Alzheimer’s disease(AD) is one of the most important progressive neurological diseases, which is characterized by the formation, misfolding, and aggregation of β-amyloid protein(Aβ). Based on the special blood brain barrier(BBB) system and protein structure of Aβ, a variety of multifunctional Aβ fluorescent probes with high sensitivity, facile operation, and low toxicity, were developed for the detection and treatment of AD. This review respectively focused on the imaging detection and therapy of Aβ, and systematically reviewed the chemical regulation strategy for brain-target design, wavelength regulation, and integration of diagnosis with treatment. In the end, the perspective for the multifunctional fluorescent Aβ probes was also discussed.

Key words: Alzheimer’s disease, β-Amyloid protein, Fluorescence, Theranostic

CLC Number: 

TrendMD: